Hangzhou, China

Thermo Fisher’s new 80,000-square-meter current Good Manufacturing Practices (cGMP) facility offers integrated clinical and commercial drug substance and drug product capabilities, including process development, cell line development, biologics drug substance manufacturing and aseptic fill-finish.

Specialized Biologics Capabilities

• Integrated drug substance and drug Product manufacturing capabilities
• In house analytical expertise, QC and QA
• Expertise in fed batch and perfusion process
• In house and partnered cell line development
• Single use technologies and flexible facility design
• Upstream & downstream process development expertise

Aseptic manufacturing and fill finish capabilities

• Prefilled syringes
• Prefilled cartridges
• Sterile liquids injectable
• Sterile lyophilized injectable
• From clinical to commercial scale filling

Learn more about the specific equipment and capabilities at this site by downloading our complete Site Fact Sheet.